We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2025 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Tests for Influenza Virus Types A and B

By LabMedica International staff writers
Posted on 11 Dec 2008
A new range of valuable diagnostic tools for the detection of respiratory disease caused by influenza virus Types A and B are now available.

The IMAGEN Influenza virus A and B test is used for the detection and differentiation between Influenza A virus and Influenza B virus in clinical specimens, or for the confirmation and differentiation of Influenza virus A and B in cell cultures. Monoclonal antibodies, specific to either virus are joined to fluorescein isothiocyanate (FITC) in a one-step, direct immunofluorescence technique. Specimens are incubated with the FITC conjugated antibody reagents for 15 minutes. The samples are then mounted and viewed microscopically using epifluorescence illumination; if either Influenza virus types are present, the corresponding reagent produces a characteristic bright apple green fluorescence within the cytoplasm and nucleus of the cells, which contrasts with the red background staining of uninfected cells.

The Xpect Flu A&B test detects and differentiates Influenza Types A and B directly from nose and throat swabs and provides a clearly visual result that is easily interpreted in just 20 minutes; no specialized equipment or expertise is required. The simplicity of the test makes it ideal for use in laboratories of any size or in a near patient setting, allowing medical professionals to test patients quickly in surgeries, community hospitals, and care homes. Both the Xpect Flu and the IMAGEN are products of Oxoid (Cambridge, United Kingdom).

Influenza virus infections peak in the winter months and remain a major health concern. The diagnostic challenge is exacerbated by the fact that symptoms of viral respiratory infections with pathogens such as the Influenza virus, the Respiratory Syncytial virus, and Adenovirus are often difficult to differentiate from those caused by other pathogens, such as bacteria or fungi. Since antiviral agents are being more commonly used, rapid identification of the causative agent is increasingly important to allow the correct treatment option to be determined, enabling effective management and control of flu outbreaks.

Related Links:
Oxoid


New
Gold Member
Hematology Analyzer
Medonic M32B
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit

Latest Microbiology News

Saliva Test Detects Implant-Related Microbial Risks
11 Dec 2008  |   Microbiology

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance
11 Dec 2008  |   Microbiology

Early Detection of Gut Microbiota Metabolite Linked to Atherosclerosis Could Revolutionize Diagnosis
11 Dec 2008  |   Microbiology